Mike Ouimette - Jan 23, 2023 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role
General Counsel & Corp. Sec'y
Signature
/s/ Mike Ouimette
Stock symbol
PLRX
Transactions as of
Jan 23, 2023
Transactions value $
-$322,078
Form type
4
Date filed
1/25/2023, 08:00 PM
Previous filing
Dec 23, 2022
Next filing
Jan 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLRX Common Stock Options Exercise $119K +10K +168.15% $11.86 15.9K Jan 23, 2023 Direct
transaction PLRX Common Stock Options Exercise $243K +10K +62.71% $24.32 25.9K Jan 23, 2023 Direct
transaction PLRX Common Stock Sale -$684K -20K -77.08% $34.19 5.95K Jan 23, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLRX Stock Option (right to buy) Options Exercise $0 -10K -11.49% $0.00 77K Jan 23, 2023 Common Stock 10K $11.86 Direct F2
transaction PLRX Stock Option (right to buy) Options Exercise $0 -10K -9.24% $0.00 98.2K Jan 23, 2023 Common Stock 10K $24.32 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 4, 2022.
F2 1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2022, subject to the Reporting Person's continuous service to the Issuer on each such date.
F3 25% of the shares subject to such option vested on October 1, 2021 and 1/48th of the shares subject to the option vest in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.